Talk:Fluticasone furoate/umeclidinium bromide/vilanterol
| This is the talk page for discussing improvements to the Fluticasone furoate/umeclidinium bromide/vilanterol article. This is not a forum for general discussion of the article's subject. |
Article policies
|
| Find medical sources: Source guidelines · PubMed · Cochrane · DOAJ · Gale · OpenMD · ScienceDirect · Springer · Trip · Wiley · TWL |
 | A fact from Fluticasone furoate/umeclidinium bromide/vilanterol appeared on Wikipedia's Main Page in the Did you know column on 6 August 2020 (check views). The text of the entry was as follows:
|  |
 | This article is rated C-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | ||||||||||||||||||||
| |||||||||||||||||||||
 | Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Fluticasone furoate/umeclidinium bromide/vilanterol.
|
Did you know nomination
[edit]- The following is an archived discussion of the DYK nomination of the article below. Please do not modify this page. Subsequent comments should be made on the appropriate discussion page (such as this nomination's talk page, the article's talk page or Wikipedia talk:Did you know), unless there is consensus to re-open the discussion at this page. No further edits should be made to this page.
The result was: promoted by The Squirrel Conspiracy (talk) 23:14, 31 July 2020 (UTC)
( )
- ... that the COVID-19 pandemic has caused delays in regulatory decisions regarding medications like fluticasone furoate/umeclidinium bromide/vilanterol? Source: 1 and 2
- Reviewed: Li Zaiping
- Comment: Expanded from ~400 characters on July 10th to now >6400 characters.
5x expanded by Biochemistry&Love (talk). Self-nominated at 00:23, 12 July 2020 (UTC).
Article has been expanded fivefold, is longer than 1500 characters, and looks well referenced. The hook is stated in the article, backed with the relevant inline citations, and is under 200 characters. Hook looks interesting. No signs of plagiarism or close paraphrasing. QPQ is done. Should be ready for promotion.— Preceding unsigned comment added by Shuipzv3 (talk • contribs) 11:45, 29 July 2020 (UTC)
- Thank you for your review.―Biochemistry🙴❤ 19:01, 29 July 2020 (UTC)
FF/UMEC/VI, COPD, ICS/LABA, LABA/LAMA, ICS/LABA/LAMA
[edit]I suggest we reduce the use of the abbreviations and acronyms to make it easier to read. Whywhenwhohow (talk) 17:15, 12 July 2020 (UTC)
- Eep. Now that I look over the page, it does seem like there are an awful many of them. What do you think about using abbreviations on a per level-2 section basis? That is, e.g., in "Adverse Effects," redefining "ICS" since it has not been previously abbreviated in that section. Do you think that would be helpful?―Biochemistry🙴❤ 17:50, 12 July 2020 (UTC)
- Yes, articles may not be read top to bottom and that would help readers who start with a specific section. Consider using alternatives like "the combination" instead of FF/UMEC/VI. The audience is the lay public. Whywhenwhohow (talk) 19:00, 12 July 2020 (UTC)
- I appreciate your point. I will make some edits to this effect.―Biochemistry🙴❤ 16:36, 13 July 2020 (UTC)
- Yes, articles may not be read top to bottom and that would help readers who start with a specific section. Consider using alternatives like "the combination" instead of FF/UMEC/VI. The audience is the lay public. Whywhenwhohow (talk) 19:00, 12 July 2020 (UTC)